G1 therapeutics, inc. (GTHX)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Dec'16
Assets
Current assets
Cash and cash equivalents

242,402

269,208

299,933

324,911

347,797

369,290

390,524

188,227

194,387

103,812

118,380

132,675

47,305

Restricted cash

63

63

63

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

1,124

1,732

2,984

3,366

1,087

843

1,489

1,662

796

849

655

1,093

596

Total current assets

243,589

271,003

302,980

328,277

348,884

370,133

392,013

189,889

195,183

104,661

119,035

133,768

47,901

Property and equipment, net

3,371

3,538

3,618

1,515

1,343

1,137

1,006

711

558

510

516

333

311

Restricted cash

437

437

437

500

-

-

-

-

-

-

-

-

-

Operating lease assets

9,117

9,853

10,151

1,361

1,448

-

-

-

-

-

-

-

-

Total assets

256,514

284,831

317,186

331,653

351,675

371,270

393,019

190,600

195,741

105,171

119,551

134,101

48,212

Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable

4,703

3,684

7,236

3,292

3,076

3,377

2,752

3,311

3,872

4,184

4,234

5,132

2,605

Accrued expenses

12,682

15,403

13,514

14,232

8,112

8,985

10,922

10,686

8,635

7,520

6,187

5,278

2,853

Other current liabilities

1,063

682

472

369

361

-

-

-

-

-

-

-

-

Warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

167

Total current liabilities

18,448

19,769

21,222

17,893

11,549

12,362

13,674

13,997

12,507

11,704

10,421

10,410

5,625

Operating lease liabilities

8,616

9,535

9,845

1,090

1,185

-

-

-

-

-

-

-

-

Other non-current liabilities

-

-

-

-

-

88

90

79

79

79

-

-

-

Total liabilities

27,064

29,304

31,067

18,983

12,734

12,450

13,764

14,076

12,586

11,783

-

-

5,625

Commitments and contingencies

-

-

-

-

-

-

-

-

-

-

0

0

0

Stockholders’ equity
Common stock, $0.0001 par value, 120,000,000 shares authorized as of March 31, 2020 and December 31, 2019, respectively; 37,763,926 and 37,638,260 shares issued as of March 31, 2020 and December 31, 2019, respectively; 37,737,260 and 37,611,594 shares outstanding as of March 31, 2020 and December 31, 2019, respectively

4

4

4

4

4

4

4

3

3

3

3

3

-

Treasury stock, 26,666 shares

8

8

8

8

8

8

8

8

8

8

8

8

8

Additional paid-in capital

597,330

592,384

587,535

581,722

577,303

573,230

569,574

346,926

332,688

222,511

221,272

220,232

-

Accumulated deficit

-367,876

-336,853

-301,412

-269,048

-238,358

-214,406

-190,315

-170,397

-149,528

-129,118

-112,137

-96,536

-64,985

Total stockholders’ equity

229,450

255,527

286,119

312,670

338,941

358,820

379,255

176,524

183,155

93,388

109,130

123,691

-64,993

Total liabilities and stockholders' equity

256,514

284,831

317,186

331,653

351,675

371,270

393,019

190,600

195,741

105,171

119,551

134,101

48,212